ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs MXN
16.6086
0.00%
Brent Oil
83.76
0.00%
Bitcoin
66,935.60
-0.22%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Vincerx Inc (VINC)

  7. Vincerx Inc (VINC) Noticias

VINC

Vincerx (VINC)

Vincerx Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:VINC
FechaHoraFuenteTítuloSímboloCompañía
14/05/202415:24Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VINCVincerx Inc
14/05/202415:21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VINCVincerx Inc
14/05/202415:15GlobeNewswire Inc.Vincerx Pharma Reports First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:VINCVincerx Inc
25/04/202423:27GlobeNewswire Inc.Vincerx Pharma Announces Pricing of Underwritten Public Offering of Common Stock and WarrantsNASDAQ:VINCVincerx Inc
25/04/202415:01GlobeNewswire Inc.Vincerx Pharma Announces Proposed Underwritten Public Offering of Common Stock and WarrantsNASDAQ:VINCVincerx Inc
08/04/202415:30GlobeNewswire Inc.Vincerx Pharma Presents Positive Preliminary Phase 1 Data for VIP236 and Updates on Pipeline Progress at the American Association for Cancer Research (AACR) Annual Meeting 2024 NASDAQ:VINCVincerx Inc
01/04/202407:00GlobeNewswire Inc.Vincerx to Host Virtual Investor Event Reviewing Preliminary Phase 1 VIP236 Data Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024NASDAQ:VINCVincerx Inc
29/03/202414:20GlobeNewswire Inc.Vincerx Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate UpdateNASDAQ:VINCVincerx Inc
08/03/202419:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VINCVincerx Inc
05/03/202415:31GlobeNewswire Inc.Vincerx to Present Three Posters at the American Association for Cancer Research (AACR) Annual Meeting 2024NASDAQ:VINCVincerx Inc
13/10/202308:12GlobeNewswire Inc.New to The Street Airs Televised Corporate Interviews Episodes 521 and 522 as Sponsored Programming on Bloomberg TV and The Fox Business NetworkNASDAQ:VINCVincerx Inc
06/10/202308:30GlobeNewswire Inc.New to The Street Announces TV Corporate Appearances, broadcasting Episode 518 on Newsmax and Episode 519 on FOX Business Network, Airings start on Saturday, October 7, 2023, at 3:30 PM ETNASDAQ:VINCVincerx Inc
20/06/202315:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VINCVincerx Inc
11/05/202315:02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:VINCVincerx Inc
12/04/202315:14Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:VINCVincerx Inc
28/03/202316:07Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:VINCVincerx Inc
28/03/202315:50Edgar (US Regulatory)Annual Report (10-k)NASDAQ:VINCVincerx Inc
16/02/202315:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VINCVincerx Inc
10/02/202315:02Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:VINCVincerx Inc
13/11/202221:55TipRanksSVB Securities Sticks to Its Buy Rating for Vincerx Pharma Inc (VINC)NASDAQ:VINCVincerx Inc
06/11/202221:35TipRanksSVB Securities Remains a Buy on Vincerx Pharma Inc (VINC)NASDAQ:VINCVincerx Inc
12/08/202207:36TipRanksVincerx Pharma Inc (VINC) Receives a Buy from SVB SecuritiesNASDAQ:VINCVincerx Inc
07/06/202207:35TipRanksAnalysts Offer Insights on Healthcare Companies: Novo Nordisk (NVO) and Vincerx Pharma Inc (VINC)NASDAQ:VINCVincerx Inc
13/05/202223:20TipRanksVincera Pharma (VINC) Receives a Buy from SVB SecuritiesNASDAQ:VINCVincerx Inc
13/05/202207:39TipRanksChardan Capital Sticks to Its Buy Rating for Vincera Pharma (VINC)NASDAQ:VINCVincerx Inc
11/04/202221:05TipRanksAnalysts Are Bullish on Top Healthcare Stocks: Genocea Biosciences (GNCA), Blueprint Medicines (BPMC)NASDAQ:VINCVincerx Inc
30/03/202209:29TipRanksLeerink Partners Thinks Vincera Pharma’s Stock is Going to RecoverNASDAQ:VINCVincerx Inc
29/03/202211:25TipRanksH.C. Wainwright Thinks Vincera Pharma’s Stock is Going to RecoverNASDAQ:VINCVincerx Inc
10/03/202205:01TipRanksVincera Pharma (VINC) Gets a Buy Rating from H.C. WainwrightNASDAQ:VINCVincerx Inc
10/02/202211:41Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:VINCVincerx Inc
 Showing the most relevant articles for your search:NASDAQ:VINC

Su Consulta Reciente

BOV
EAIN34
Electronic Arts
NYSE
GRND
Grindr
NYSE
LGC.U
Legacy Acquisition
NASDAQ
AAXUJXX
Hsbc Bank Usa Na Capped ...
LQID
DOGEBTC
COIN
IQCGBP
IQ Cash
USOTC
CCHWF
Cannabist (QX)
USOTC
JPEIF
JP Morgan ETFs Ireland I... (CE)
USOTC
DTTVY
Dish TV India (CE)
EU
BAS
Basilix
NASDAQ
BFRI
Biofrontera
NASDAQ
AAZZJXX
Hsbc Bank Usa Na Dual Di...
UNSW
YFFETH
yff.finance
BOV
BPFV39
Global X Funds
TSXV
CEQ
Criterium Energy
LSE
39VR
Res.mtg 17 A2ca
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados